The Effect of Inflammatory Markers in Patients with Diabetes Mellitus
Article Sidebar
Main Article Content
Abstract
The purposes of this research are to identify the significance of inflammatory substances in individuals with type 2 diabetes mellitus and investigate the relationship involving inflammatory responses and illness duration. The fifty specimens used in the present investigation were split between thirty specimens of individuals who had diabetes with type 2 and twenty specimens about the unaffected population. In this investigation, the body mass index (BMI), HbAIC, as well as levels of C-reactive proteins among individuals having diabetes type 2 and the unaffected population were calculated. also shows the relationship between HbAIC, CRP, and a body mass index HbA1C, CRRACTIVE PROTINE, and a body mass index all increased significantly (p<0.05) throughout the present study. Additionally, in individuals with diabetes with type 2, there was a substantial (p<0.05) positive association among the Creative Protein and body mass index (B and a significant (p<0.05) beneficial relationship among the C Reactive protein and HbA1C. According according to the research's findings, those suffering from type 2 diabetes had higher levels of inflammation-related markers, and their HbAIC readings increased in tandem alongside the progression of the illness, suggesting an advantageous correlation across the two variables.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Petersmann, A. (2018). Definition, Classification and Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol Diabetes, 126(7), 406-410.
Dahlström, E., & Sandholm, N. (2017). Progress in defining the genetic basis of diabetic complications. Current diabetes reports, 17(9), 1-13.
IDF Diabetes Atlas, Ninth edition, 2019. International diabetes federation.
American Diabetes Association. (2020). 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2020. Diabetes care, 43(Supplement_1), S14 S31.
Niroomand, M., Ghasemi, S. N., Karimi-Sari, H., & Khosravi, M. H. (2017). Knowledge, attitude, and practice of Iranian internists regarding diabetes: a cross sectional study. Diabetes & metabolism journal, 41(3), 179-186.
Da Silva Xavier, G. (2018). The cells of the islets of Langerhans. Journal of clinical medicine, 7(3), 54.
Vanhorebeek, I., Langouche, L., & Van den Berghe, G. (2007, February). Modulating the endocrine response in sepsis: insulin and blood glucose control. In Novartis Foundation symposium (Vol. 280, p. 204). Chichester; New York; John Wiley; 1999.
Van den Berghe, G. (2004). How does blood glucose control with insulin save lives in intensive care?. The Journal of clinical investigation, 114(9), 1187-1195.
Wu, Y., Ding, Y., Tanaka, Y., & Zhang, W. (2014). Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. International journal of medical sciences, 11(11), 1185.
Alva, M. L., Hoerger, T. J., Zhang, P., & Gregg, E. W. (2017). Identifying risk for type 2 diabetes in different age cohorts: does one size fit all?. BMJ Open Diabetes Research and Care, 5(1), e000447.
Fowler, M. J. (2008). Microvascular and macrovascular complications of diabetes. Clinical diabetes, 26(2), 77-82.
Lotfy, M., Adeghate, J., Kalasz, H., Singh, J., & Adeghate, E. (2017). Chronic complications of diabetes mellitus: a mini review. Current diabetes reviews, 13(1), 3-10.
Alzamil, H. (2020). Elevated serum TNF-α is related to obesity in type 2 diabetes mellitus and is associated with glycemic control and insulin resistance. Journal of obesity, 2020.
Gray, N., Picone, G., Sloan, F., & Yashkin, A. (2015). The relationship between BMI and onset of diabetes mellitus and its complications. South Med J., 108(1), 29-36.
Appel, L. J., Clark, J. M., Yeh, H. C., Wang, N. Y., Coughlin, J. W., Daumit, G., ... & Brancati, F. L. (2011). Comparative effectiveness of weight-loss interventions in clinical practice. England Journal of Medicine, 365(21), 1959-1968.
Al-Attaby, A. K. T., & Al-Lami, M. Q. D. (2019). Effects of duration and complications of type 2 diabetes mellitus on diabetic related parameters, adipocytokines and calcium regulating hormones. Iraqi Journal of Science, 2335-2361.
Chakraborty, N. and Mandal, A. K. (2016). A study on complications of type 2 diabetes mellitus in a diabetes clinic of a tertiary care hospital, Kolkata, west Bengal. IOSR JDMS, 15(10):,29-33.
Piccini, B., Artuso, R., Lenzi, L., Guasti, M., Braccesi, G., Barni, F., ... & Toni, S. (2016). Clinical and molecular characterization of a novel INS mutation identified in patients with MODY phenotype. European journal of medical genetics, 59(11), 590-595.
Bowman, P., Flanagan, S. E., Edghill, E. L., Damhuis, A., Shepherd, M. H., Paisey, R., ... & Ellard, S. (2012). Heterozygous ABCC8 mutations are a cause of MODY. Diabetologia, 55(1), 123-127.
Ito, H., Omoto, T., Abe, M., Matsumoto, S., Shinozaki, M., Nishio, S., ... & Togane, M. (2017). Relationships between the duration of illness and the current status of diabetes in elderly patients with type 2 diabetes mellitus. Geriatrics & Gerontology International, 17(1), 24-30.
Hayashino, Y., Izumi, K., Okamura, S., Nishimura, R., Origasa, H., Tajima, N., & JDCP Study Group. (2017). Duration of diabetes and types of diabetes therapy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention prospective study 3 (JDCP study 3). Journal of diabetes investigation, 8(2), 243-249.
Agho, E. T., Owotade, F. J., Kolawole, B. A., Oyetola, E. O., & Adedeji, T. A. (2021). Salivary inflammatory biomarkers and glycated haemoglobin among patients with type 2 diabetic mellitus. BMC Oral Health, 21, 1-8.
Dezayee, Z. M. I., & Al-Nimer, M. S. M. (2016). Saliva C-reactive protein as a biomarker of metabolic syndrome in diabetic patients. Indian Journal of Dental Research, 27(4), 388.
Jeong, H., Eun, Y. H., Kim, I. Y., Park, E. J., Lee, J., Kim, H., & Jeon, C. H. (2019). C-reactive protein level as a marker for dyslipidemia, diabetes, and metabolic syndrome: results from the korean national health and nutrition examination survey. annals of the rheumatic diseases, 78, 2092-2092.
Wen, J., Liang, Y., Wang, F., Sun, L., Guo, Y., Duan, X., ... & Wang, N. (2010). C-reactive protein, gamma-glutamyltransferase and type 2 diabetes in a Chinese population. Clinica Chimica Acta, 411(3-4), 198-203.
Liu, S., Tinker, L., Song, Y., Rifai, N., Bonds, D. E., Cook, N. R., ... & Manson, J. E. (2007). A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Archives of internal medicine, 167(15), 1676-1685.
Seo, Y. H., & Shin, H. Y. (2021). Relationship between hs-CRP and HbA1c in Diabetes Mellitus Patients: 2015–2017 Korean National Health and Nutrition Examination Survey. Chonnam medical journal, 57(1), 62.
Son, N. E. (2019). Influence of ferritin levels and inflammatory markers on HbA1c in the Type 2 Diabetes mellitus patients. Pakistan journal of medical sciences, 35(4), 1030.
Timpson, N. J., Nordestgaard, B. G., Harbord, R. M., Zacho, J., Frayling, T. M., Tybjærg- Hansen, A., & Davey Smith, G. (2011). C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. International journal of obesity, 35(2), 300-308.
Saito, I. (2012). Epidemiological evidence of type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease in Japan. Circulation Journal.
Chatterjee, S., Khunti, K., & Davies, M. J. (2017). Type 2 diabetes. The lancet, 389(10085), 2239-2251.
Fukuchi, Y., Miura, Y., Nabeno, Y., Kato, Y., Osawa, T., & Naito, M. (2008). Immunohistochemical detection of oxidative stress biomarkers, dityrosine and Nε-(hexanoyl) lysine, and c-reactive protein in rabbit atherosclerotic lesions. Journal of atherosclerosis and thrombosis, 15(4), 185-192.